Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CASP6 | P55212 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | NSD2 | O96028 | 2/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.35 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3952770 | 0.83 | ALDH1A1 (0.43) | TSHRSMN1; SMN2SNCAHSD17B10ALDH1A1 | |
| SCHEMBL28456393 | 0.81 | ALDH1A1 (0.42) | TSHRSMN1; SMN2SNCAHSD17B10ALDH1A1 | |
| SCHEMBL16320747 | 0.81 | PTGS2 (0.42) | LMNAL3MBTL1 | |
| SCHEMBL6632171 | 0.81 | ALDH1A1 (0.46) | TSHRSMN1; SMN2SNCAHSD17B10ALDH1A1 | |
| SCHEMBL8388156 | 0.81 | LMNA (0.53) | LMNA | |
| SCHEMBL28580800 | 0.80 | HTR6 (0.50) | TSHRSMN1; SMN2ALDH1A1LMNAPOLB | |
| SCHEMBL1375946 | 0.79 | ALDH1A1 (0.33) | TSHRSMN1; SMN2SNCAHSD17B10ALDH1A1 | |
| SCHEMBL3823429 | 0.78 | TSHR (0.39) | TSHRSMN1; SMN2HSD17B10ALDH1A1LMNA | |
| SCHEMBL17289181 | 0.77 | ALDH1A1 (0.39) | SMN1; SMN2ALDH1A1LMNATDP1POLB | |
| SCHEMBL3823585 | 0.76 | SNCA (0.42) | TSHRSMN1; SMN2SNCAHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5811081-A | Use of hydroxybenzotriazoles for enhancing the sun protection factor of cellulosic fibre materials | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-09-22 | — | — | US | claimed |
| EP-0708197-A2 | Utilisation of hydroxybenztriazoles for increasing the sun-ray filter index of fibrous cellulosic materials | CIBA-GEIGY AG (CH) | 1996-04-24 | — | — | EP | claimed |
| EP-0087113-B1 | WATER SOLUBLE DISAZO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-09-03 | — | — | EP | claimed |
| EP-2243805-B1 | ANTHRAPYRIDONE COMPOUND OR SALT THEREOF, MAGENTA INK COMPOSITION CONTAINING THE ANTHRAPYRIDONE COMPOUND, AND COLORED BODY | NIPPON KAYAKU KK (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-7985287-B2 | Anthrapyridone compound or a salt thereof, magenta ink composition containing the anthrapyridone compound and colored product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-26 | — | — | US | disclosed |
| EP-2317307-A2 | Method of analyzing amino- and/or imino-functional compounds, and analytical reagent | Ajinomoto Co., Inc. (JP) | 2011-05-04 | — | — | EP | disclosed |
| US-20100291360-A1 | Anthrapyridone Compound Or A Salt Thereof, Magenta Ink Composition Containing The Anthrapyridone Compound and Colored Product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-11-18 | — | — | US | disclosed |
| EP-2243805-A1 | ANTHRAPYRIDONE COMPOUND OR SALT THEREOF, MAGENTA INK COMPOSITION CONTAINING THE ANTHRAPYRIDONE COMPOUND, AND COLORED BODY | Nippon Kayaku Kabushiki Kaisha (JP) | 2010-10-27 | — | — | EP | disclosed |
| CN-1616432-A | Compound,its use and pharmaceutical compositions comprising same | ELAN PHARM INC (US) | 2005-05-18 | — | — | CN | disclosed |
| US-20040231558-A1 | Has a clear hue, high light fastness and high moisture resistance | MITSUI CHEMICALS, INC. (JP) | 2004-11-25 | — | — | US | disclosed |
| CN-1171878-C | Compounds, their use and pharmaceutical compositions containing them | ������˹ҩƷ��˾ | 2004-10-20 | — | — | CN | disclosed |
| EP-0719840-A1 | Monoazo compounds and method for dyeing or printing fiber materials using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-07-03 | — | — | EP | disclosed |
| EP-0708197-A2 | Utilisation of hydroxybenztriazoles for increasing the sun-ray filter index of fibrous cellulosic materials | CIBA-GEIGY AG (CH) | 1996-04-24 | — | — | EP | disclosed |
| EP-0629667-A1 | Water-soluble fiber-reactive dyes, process for their preparation and the use thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-12-21 | — | — | EP | disclosed |
| EP-0624630-A1 | Water-soluble fiber-reactive dyes, process for their preparation and the use thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-11-17 | — | — | EP | disclosed |
| EP-0603595-A1 | Fibre reactive dyes, method for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-06-29 | — | — | EP | disclosed |
| EP-0548792-A2 | Water-soluble reactive dyes, their manufacture and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-06-30 | — | — | EP | disclosed |
| EP-0087113-B1 | WATER SOLUBLE DISAZO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-09-03 | — | — | EP | disclosed |
| EP-0087113-A2 | Water soluble disazo compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-08-31 | — | — | EP | disclosed |
| US-4040840-A | MEROCYANINE DYE HAVING ISOXAZOLE NUCLEUS AND PYRAZOLINE-5-ONE NUCLEUSN | FUJI PHOTO FILM CO., LTD. (JA) | 1977-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291360-A1 | Anthrapyridone Compound Or A Salt Thereof, Magenta Ink Composition Containing The Anthrapyridone Compound and Colored Product | MLLT3, MLLT1, H1-3 | TSHR 3602/4885SMN1; SMN2 1648/4885SNCA 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.